Escalating and de-escalating treatment in HER2-positive early breast cancer
Author:
Publisher
Elsevier BV
Subject
Radiology Nuclear Medicine and imaging,Oncology,General Medicine
Reference90 articles.
1. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987
2. The HER2 receptor in breast cancer: pathophysiology, clinical use, and new advances in therapy;Mitri;Chemother Res Pract,2012
3. Metastatic behavior of breast cancer subtypes;Kennecke;J Clin Oncol,2010
4. Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study;Sihto;Breast Cancer Res,2011
5. Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers;Chia;J Clin Oncol,2008
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Six‐Membered Aromatic Nitrogen Heterocyclic Anti‐Tumor Agents: Synthesis and Applications;The Chemical Record;2023-11-27
2. Body mass index as a prognostic factor in HER-2 positive early breast cancer patients and its effect on duration of treatment with Trastuzumab: A retrospective study;Journal of the Pakistan Medical Association;2023-05-25
3. An Open-Label, Multinational, Multicenter, Phase IIIb Study with Subcutaneous Administration of Trastuzumab in Patients with HER2-Positive Early Breast Cancer to Evaluate Patient Satisfaction;European Journal of Breast Health;2022-12-30
4. Editorial: Recent advancements in neoadjuvant chemotherapy for specific breast cancer subtypes;Frontiers in Oncology;2022-12-13
5. Analysis of Drug Classification using Mechanism of Action;Journal of Physics: Conference Series;2021-05-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3